Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Sales | 4,512 | 1,914 | 1,753 | 1,175 | 2,414 |
| Gross Profit | 1,140 | 6,340 | 1,750 | 2,170 | 2,640 |
| Operating Expenses | 10,500 | 5,760 | 5,620 | 4,810 | 5,210 |
| Operating Income | -5,988 | -3,846 | -3,867 | -3,635 | -2,796 |
| Interest Expense | 80 | 60 | 60 | 60 | 80 |
| Other Income | -3,192 | -23,664 | -153 | 635 | -44 |
| Pre-tax Income | -9,260 | -27,570 | -4,080 | -3,060 | -2,920 |
| Net Income Continuous | -5,871 | -32,004 | -4,085 | -3,062 | -2,904 |
| Net Income | $-5,871 | $-32,004 | $-4,085 | $-3,062 | $-2,904 |
| EPS Basic Total Ops | -9,803.92 | -51,820.73 | -8,403.36 | -6,302.52 | -6,302.52 |
| EPS Basic Continuous Ops | -9,785.00 | -64,008.00 | -8,170.00 | -6,124.00 | -5,808.00 |
| EPS Diluted Total Ops | -9,803.92 | -60,224.09 | -8,403.36 | -6,302.52 | -6,302.52 |
| EPS Diluted Continuous Ops | -9,785.00 | -64,008.00 | -8,170.00 | -6,124.00 | -5,808.00 |
| EBITDA(a) | $-3,838 | $-3,266 | $-3,487 | $-3,285 | $-2,316 |